Smith v. Secretary of Health and Human Services ( 2021 )


Menu:
  •     In the United States Court of Federal Claims
    OFFICE OF SPECIAL MASTERS
    No. 19-0745V
    UNPUBLISHED
    RENEE SMITH,                                            Chief Special Master Corcoran
    Petitioner,                         Filed: May 28, 2021
    v.
    Special Processing Unit (SPU);
    SECRETARY OF HEALTH AND                                 Decision Awarding Damages; Pain
    HUMAN SERVICES,                                         and Suffering; Influenza (Flu)
    Vaccine; Shoulder Injury Related to
    Respondent.                          Vaccine Administration (SIRVA)
    Bridget Candace McCullough, Muller Brazil, LLP, Dresher, PA, for Petitioner.
    Mallori Browne Openchowski,1 U.S. Department of Justice, Washington, DC, for
    Respondent.
    DECISION AWARDING DAMAGES2
    On May 20, 2019, Renee Smith filed a petition for compensation under the National
    Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.3 (the “Vaccine
    Act”). Petitioner alleged that she suffered a shoulder injury related to vaccine
    administration (“SIRVA”), a defined Table Injury, after receiving the influenza (“flu”)
    vaccine she received on September 22, 2017. Petition at 1, ¶ 2. The case was assigned
    to the Special Processing Unit (“SPU”) of the Office of Special Masters, and has been
    1
    Although Ms. Openchowski is attorney of record in this case, attorney Andrew Henning appeared for
    Respondent at the May 28, 2021 Motions Day argument.
    2
    Because this Decision contains a reasoned explanation for the action in this case, I am required to post it
    on the United States Court of Federal Claims' website in accordance with the E-Government Act of 2002.
    
    44 U.S.C. § 3501
     note (2012) (Federal Management and Promotion of Electronic Government Services).
    This means the Decision will be available to anyone with access to the internet. In accordance with
    Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the
    disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the
    identified material fits within this definition, I will redact such material from public access.
    3
    National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 
    100 Stat. 3755
    . Hereinafter, for ease
    of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
    300aa (2012).
    conceded by Respondent. Because the parties were unable to resolve damages, the
    disputed issues were addressed at a Motions Day hearing held on May 28, 2021.
    For the reasons set forth below, and as I indicated at the end of the hearing, I find
    that Petitioner is entitled to a damages award in the amount $127,281.68, representing
    $125,000.00 for her past pain and suffering, and $2,281.68 for her past lost wages.
    I.      Relevant Procedural History
    On September 23, 2020, Respondent filed a Rule 4(c) Report, conceding
    entitlement. ECF No. 26. The same day, I issued a ruling finding Petitioner was entitled
    to compensation. ECF No. 27.
    For approximately three months thereafter, the parties attempted to informally
    determine the appropriate amount of damages to be awarded in this case. See, e.g.,
    Status Report, filed Dec. 22, 2020, ECF No. 31. On February 4, 2021, they filed a status
    report indicating that although they had agreed upon an amount for Petitioner’s lost
    wages, they had reached an impasse regarding the appropriate amount for Petitioner’s
    pain and suffering. ECF No. 33. They expressed their desire to brief the issue. Id.
    The parties filed their briefs by April 21, 2021. ECF Nos. 35, 37. On April 30, 2021,
    they indicated their willingness to participate in an expedited Motions Day hearing,
    scheduled for May 28, 2021. ECF No. 39. At the conclusion of the expedited hearing,4 I
    orally informed the parties of my determination, which is more formally set forth herein.
    II.     Legal Standard
    Compensation awarded pursuant to the Vaccine Act shall include “[f]or actual and
    projected pain and suffering and emotional distress from the vaccine-related injury, an
    award not to exceed $250,000.” Section 15(a)(4). Additionally, a petitioner may recover
    “actual unreimbursable expenses incurred before the date of judgment award such
    expenses which (i) resulted from the vaccine-related injury for which petitioner seeks
    compensation, (ii) were incurred by or on behalf of the person who suffered such injury,
    and (iii) were for diagnosis, medical or other remedial care, rehabilitation . . . determined
    to be reasonably necessary.” Section 15(a)(1)(B). The petitioner bears the burden of proof
    with respect to each element of compensation requested. Brewer v. Sec’y of Health &
    Human Servs., No. 93-0092V, 
    1996 WL 147722
    , at *22-23 (Fed. Cl. Spec. Mstr. Mar. 18,
    1996).
    4
    An official recording of the proceeding was taken by court reporter, and a link to instructions on the court’s
    website detailing how to order a certified transcript or audio recording of the proceeding can be found in the
    minute entries for this proceeding. Minute Entry, dated May 28, 2021; see also
    www.uscfc.uscourts.gov/trans (last visited May 28, 2021).
    2
    There is no mathematic formula for assigning a monetary value to a person’s pain
    and suffering and emotional distress. I.D. v. Sec’y of Health & Human Servs., No. 04-
    1593V, 
    2013 WL 2448125
    , at *9 (Fed. Cl. Spec. Mstr. May 14, 2013) (“[a]wards for
    emotional distress are inherently subjective and cannot be determined by using a
    mathematical formula”); Stansfield v. Sec’y of Health & Human Servs., No. 93-0172V,
    
    1996 WL 300594
    , at *3 (Fed. Cl. Spec. Mstr. May 22, 1996) (“the assessment of pain and
    suffering is inherently a subjective evaluation”). Factors to be considered when
    determining an award for pain and suffering include: 1) awareness of the injury; 2) severity
    of the injury; and 3) duration of the suffering. I.D., 
    2013 WL 2448125
    , at *9 (quoting
    McAllister v. Sec’y of Health & Human Servs., No 91-1037V, 
    1993 WL 777030
    , at *3 (Fed.
    Cl. Spec. Mstr. Mar. 26, 1993), vacated and remanded on other grounds, 
    70 F.3d 1240
    (Fed. Cir. 1995)).
    I may also consider prior pain and suffering awards to aid my resolution of the
    appropriate amount of compensation for pain and suffering in this case. See, e.g., Doe
    34 v. Sec’y of Health & Human Servs., 
    87 Fed. Cl. 758
    , 768 (2009) (finding that “there is
    nothing improper in the chief special master’s decision to refer to damages for pain and
    suffering awarded in other cases as an aid in determining the proper amount of damages
    in this case.”). And, of course, I may rely on my own experience (along with my
    predecessor Chief Special Masters) adjudicating similar claims.5 Hodges v. Sec’y of
    Health & Human Servs., 
    9 F.3d 958
    , 961 (Fed. Cir. 1993) (noting that Congress
    contemplated the special masters would use their accumulated expertise in the field of
    vaccine injuries to judge the merits of individual claims).
    III.    Appropriate Compensation for Petitioner’s Pain and Suffering
    The parties agree Petitioner should be awarded $2,281.68 in compensation for her
    past lost wages. Petitioner’s Brief in Support of Damages (“Pet. Brief”) at 1; Respondent’s
    Brief on Damages (“Res. Brief”) at 1 n.1. Thus, the only issue to be determined is the
    appropriate amount of compensation for Petitioner’s pain and suffering.
    Petitioner has requested an amount of $135,000.00 for past/actual pain and
    suffering. Pet. Brief at 1. In her brief, she emphasized the short, three-day period between
    her injury and when she first sought treatment, the difficulties she experienced performing
    her job and time she was unable to work, the need for surgery after relying on more
    conservative treatment for eight months, and the overall length of her injury, thirteen
    5
    From July 2014 until September 2015, the SPU was overseen by former Chief Special Master Vowell. For
    the next four years, until September 30, 2019, all SPU cases, including the majority of SIRVA claims, were
    assigned to former Chief Special Master Dorsey. In early October 2019, the majority of SPU cases were
    reassigned to me as the current Chief Special Master.
    3
    months. Id. at 8-9. She compared the facts and circumstances in her case with those
    experienced by the petitioners in Dobbins, Nute, and Rafftery, who received awards
    ranging from $125,000.00 to $127,500.00 for their past pain and suffering. 6 Pet. Brief at
    9-10. Maintaining that her injury is most like the one in Rafferty (where the claimant
    received $127,500.00), Petitioner asserted that she should receive a greater award
    because the Rafferty petitioner waited longer, 60 days, before seeking treatment;
    underwent surgery after only five months, as opposed to the eight months Petitioner
    waited; and suffered her injury for a shorter overall duration, eleven months. Id. at 10.
    In reaction, Respondent maintained Petitioner should be awarded no more than
    $85,000.00 for her past pain and suffering. Res. Brief at 1. While arguing that this lower
    amount is more appropriate, he emphasized the good recovery Petitioner experienced
    thirteen months post-vaccination. Based on the improvement shown prior to surgery -
    from the initial conservative treatment Petitioner received, the results of Petitioner’s MRI,
    and the second orthopedist’s seen by Petitioner for her worker’s compensation claim,
    Respondent argued that the surgery undergone by Petitioner was not needed. Id. at 8.
    During oral argument, Respondent’s counsel Mr. Henning asserted Petitioner was
    motivated to undergo surgery, not by the pain and suffering she was enduring, but rather
    by a desire to resolve her injury more quickly.
    Rather than citing comparable reasoned damages decisions, Respondent argued
    that the large number of proffered cases in SPU is a more accurate representation of the
    appropriate of damages to be awarded and criticized the “meeting-in-the-middle” method
    that he believes is being utilized by the special masters to split the difference between
    each side’s pain and suffering figure. Res. Brief at 5-6. He also proposed that awards
    outside the Vaccine Program should be considered since he believes Program awards
    are unreasonably inflated. Respondent and Id. at 6-7.
    As I informed the parties at hearing, I have previously addressed the more general
    arguments about calculation of pain and suffering damages made by Respondent during
    other Motions Day oral arguments and in other damages decisions. While noting that this
    end result may occur in some cases (and thereby disappoint both sides as a result), I
    have in fact explicitly rejected the “meeting-in-the-middle” method Respondent claims is
    being used, observing that “each petitioner deserves an examination of the specific facts
    and circumstances in her or his case.” Sakovits v. Sec’y of Health & Human Servs., No.
    17-1028V, 
    2020 WL 3729420
    , at *3 (Fed. Cl. Spec. Mstr. June 4, 2020). I also have
    rejected Respondent’s argument that the amounts awarded in proffered cases are a more
    6
    Rafferty v. Sec’y of Health & Human Servs., No. 17-1906V, 
    2020 WL 3495956
     (Fed. Cl. Spec. Mstr. May
    21, 2020) (awarding $127,500.00 for pain and suffering and $4,154.04 for actual unreimbursable
    expenses); Nute v. Sec’y of Health & Human Servs., No. 18-0140V, 
    2019 WL 6125008
     (Fed. Cl. Spec.
    Mstr. Sept. 6, 2019) (awarding $125,000.00 for pain and suffering); Dobbins v. Sec’y of Health & Human
    Servs., No. 16-0854V, 
    2018 WL 4611267
     (Fed. Cl. Spec. Mstr. Aug. 15, 2018) (awarding $125,000.00 for
    pain and suffering and $3,143.80 for actual unreimbursable expenses).
    4
    accurate gauge of the appropriate amount to be awarded than reasoned decisions from
    the court and special masters. 
    Id. at *4
    . While “settled cases and proffers provide some
    evidence of the kinds of awards received overall in comparable cases,” they are not as
    persuasive as reasoned decisions from a judicial neutral. 
    Id.
     (emphasis in original). Taken
    as a whole, however, the data from these decisions can be a helpful gauge of the
    compensation being awarded in SPU SIRVA cases. See Johnson v. Sec’y of Health &
    Human Servs., No. 18-1486V, 
    2021 WL 836891
    , at *4-5 (Fed. Cl. Spec. Mstr. Jan. 25,
    2021) (for the most recent data in SPU SIRVA cases).
    I also have not previously given great weight to Respondent’s citation to pain and
    suffering determinations from traditional tort system state court cases, noting that
    Congress intended the “no-fault” system established in the Vaccine Program to be
    generous. H.R. REP. NO. 99-908, at 12-13 reprinted in 1986 U.S.C.C.A.N. 6344, 6353-54.
    Thus, Vaccine Program compensation will inherently be greater than what is awarded in
    civil actions elsewhere. Additionally, the descriptions of the traditional tort system cases
    proposed by Respondent often lack basic information needed for comparison. Rafferty v.
    Sec’y of Health & Human Servs., No. 17-1906V, 
    2020 WL 3495956
    , at *18 (Fed. Cl. Spec.
    Mstr. May 21, 2020). As a result, “SIRVA awards in the Vaccine Program are self-
    evidently more relevant and apposite.” 
    Id.
    In arguing for a lower pain and suffering figure herein, Respondent cited no prior
    reasoned decisions from the Vaccine Program. During the proceeding held during the
    expedited Motions Day in this case, I reminded Respondent’s counsel that if Respondent
    wants to prevail in future cases, it is crucial that he offer comparable awards to support
    the argued for amount(s). And jury awards in other jurisdictions must be linked to the
    vaccine case at hand.
    In this case, the medical records establish that three days after vaccination,
    Petitioner sought medical care, complaining of severe pain, limited range of motion
    (“ROM”), and difficulty performing daily tasks. Exhibit 2 at 83. An ultrasound of the
    injection site showed fluid in the subacromial subdeltoid bursa. 
    Id. at 96
    . Petitioner was
    placed on two weeks of medical leave. Petitioner’s PCP described her injury as “urgent”
    and instructed that “she needs ortho ASAP.” 
    Id. at 108
    .
    When seen by an orthopedist a few days later, on September 28, 2017, she
    reported a maximum pain level of six out of ten. Exhibit 3 at 25. The orthopedist
    administered a cortisone injection. 
    Id. at 23-24
    . When Petitioner returned on October 5,
    2017, she indicated the injection had reduced her pain. However, she reported the same
    maximum pain level of six out of ten. 
    Id. at 46
    . When evaluated for physical therapy that
    same day, she reported pain at a level of five out of ten at rest, increasing to a maximum
    level of seven or eight out of ten. Exhibit 3 at 36. She also indicated she had been unable
    to move her arm the night of vaccination. 
    Id.
    5
    Petitioner’s ROM improved with PT, but her pain continued. Exhibit 2 at 133-34.
    Approximately one month after vaccination, Petitioner’s right shoulder still was painful,
    but she had more mobility. 
    Id. at 156
    . Petitioner was able to return to work on October 24,
    2017, one-month post-vaccination. 
    Id. at 177
    . Approximately two weeks later, her
    maximum pain level had decreased to two out of ten. Exhibit 3 at 73. From early October
    through late November 2017, Petitioner underwent 14 PT sessions. Exhibit 4 at 5-206.
    An MRI, performed in early December 2017, revealed “a partial thickness bursal
    surface tear” and “a mild amount of fluid within the subacromial/subdeltoid bursal.” Exhibit
    3 at 92. In early December 2017, after reaching a plateau in her improvement, Petitioner
    decided to undergo arthroscopic surgery. 
    Id. at 123
    . Due to her worker’s compensation
    claim, she was required by obtain a second orthopedic opinion. Id.; Exhibit 8 at 5. The
    second orthopedist opined Petitioner’s injury could resolve with more conservative
    treatment, such as continued PT and one or two more cortisone injections. 
    Id. at 6
    .
    Despite this second opinion, Petitioner underwent arthroscopic surgery on May 14,
    2018. Exhibit 5 at 18-19. She was able to return to light duty, sedentary work,
    approximately one-month post-surgery. Exhibit 3 at 8. After attending 35 PT sessions,
    from mid-May through late September 2018, Petitioner’s SIRVA had improved to the point
    where she had only tolerable pain when performing strenuous activities such as
    vacuuming and cleaning her car, which otherwise was at a level of zero out of ten. Exhibit
    4 at 629, 854. When seen again by the orthopedist on October 30, 2018, approximately
    thirteen months after vaccination, Petitioner “[wa]s cleared to return to work w[ith] no
    further restrictions.” Exhibit 3 at 353.
    In summary, the medical records show Petitioner suffered immediate pain and
    limited ROM after receiving a flu vaccine on September 22, 2017. She reported moderate
    to severe levels of pain and was unable to work for a month post-vaccination. She
    obtained some improvement, initially regarding her ROM and then in her level of pain,
    from one cortisone injection and 14 sessions of PT over a period of two months. She
    underwent arthroscopic surgery in May 2018, approximately eight months after
    vaccination. After 35 sessions of post-surgery PT during a more than five-month period,
    Petitioner recovered to the point where she was experiencing only occasionally pain with
    strenuous activity.
    While I considered Respondent’s argument regarding the improvement Petitioner
    experienced prior to surgery, the procedure she underwent still constitutes a surgical
    intervention, even if driven in part by Petitioner’s preference. Her choice was no doubt
    based upon the pain and other symptoms she was experiencing, and a desire to shorten
    the duration of her injury through such surgical intervention is evidence of the suffering
    Petitioner was experiencing.
    6
    I find the range proposed by Petitioner, arising from prior Program reasoned
    decisions, provides a persuasive framework for determining the level of the pain and
    suffering award to be issued in this case. In particular, Petitioner’s SIRVA more closely
    resembles the injury suffered by the Nute petitioner – making the past pain and suffering
    award from that case the better comparable herein. Ms. Smith, like the Nute petitioner,
    experienced moderate to severe pain and limited ROM for approximately eight months
    before undergoing arthroscopic surgery, followed by substantial PT. Nute, 
    2019 WL 6125008
    , at *12. Thereafter, they both recovered well. 
    Id.
     Although the circumstances in
    Rafferty are also comparable to those experienced by Petitioner, the Rafferty petitioner’s
    surgery revealed more extensive damage and resulted in residual pain and suffering due
    to scarring. Rafferty, 
    2020 WL 3495956
    , at *15-16.
    IV.     Conclusion
    For all of the reasons discussed above and based on consideration of the record
    as a whole, I find that $125,000.00 represents a fair and appropriate amount of
    compensation for Petitioner’s past pain and suffering. I also find that Petitioner is
    entitled to the agreed upon amount of $2,281.68 for her past lost wages.
    I thus award Petitioner a lump sum payment of $127,281.68, representing
    $125,000.00 for her actual pain and suffering and $2,281.68 for her actual lost
    wages in the form of a check payable to Petitioner. This amount represents
    compensation for all damages that would be available under Section 15(a).
    The Clerk of the Court is directed to enter judgment in accordance with this
    decision.7
    IT IS SO ORDERED.
    s/Brian H. Corcoran
    Brian H. Corcoran
    Chief Special Master
    7
    Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
    renouncing the right to seek review.
    7
    

Document Info

Docket Number: 19-745

Judges: Brian H. Corcoran

Filed Date: 6/28/2021

Precedential Status: Non-Precedential

Modified Date: 6/28/2021